The coverage in England of US-approved cancer drugs reply: in reply

Cherla, A., Naci, H.

(2021). The coverage in England of US-approved cancer drugs reply: in reply. JAMA Internal Medicine, 181(9), 1263 - 1264. https://doi.org/10.1001/jamainternmed.2021.3339

Copy

Item Type	Article
Copyright holders	© 2021 American Medical Association
Departments	LSE > Academic Departments > Health Policy
DOI	10.1001/jamainternmed.2021.3339
Date Deposited	14 Jun 2022
URI	https://researchonline.lse.ac.uk/id/eprint/115301

Explore Further

Naci, Huseyin
Mossialos, Elias

RA Public aspects of medicine
RM Therapeutics. Pharmacology

https://www.lse.ac.uk/health-policy/people/huseyin-naci-phd-mhs (Author)
https://www.lse.ac.uk/health-policy/people/professor-elias-mossialos (Author)
https://www.scopus.com/pages/publications/85109888871 (Scopus publication)
https://jamanetwork.com/journals/jamainternalmedic... (Official URL)

Full text not available from this repository.

Downloads

View more statistics

The coverage in England of US-approved cancer drugs reply: in reply

Explore Further

Export as